Sutro Biopharma (STRO)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
264,967,000
EV to revenue ratio (TTM)
2.478
EV to ebitda
41.71
Financial Performance
Revenue (TTM)
45,702,000
Gross profit (TTM)
-99,041,000
EBITDA
-125,795,000
Profitability
Operating margin (TTM)
-301.70%
Profit margin
0.00%
Return on assets (TTM)
-36.10%
Return on equity (TTM)
-1,810.00%
Per Share Metrics
Revenue per share (TTM)
3.92
EPS
-17.37
Diluted EPS (TTM)
-17.37
Book value
-6.23
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
10.03
PEG ratio
Price to sales ratio (TTM)
5.8
Price to book ratio (TTM)
2.111
Growth
Quarterly earnings growth (YoY)
-84.60%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
3
Buy
10
Hold
0
Sell
0
Strong sell
1
Risk & Volatility
Beta
1.491